Sema4 Achieves HITRUST CSF Certification
06. April 2022 08:00 ET
|
Sema4
STAMFORD, Conn., April 06, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that its health intelligence platform,...
BioIntelliSense and Renown Health Announce Strategic Collaboration to Provide Continuous Medical Grade Patient Monitoring from In-Hospital to Home
06. Dezember 2021 10:59 ET
|
Renown Health
DENVER , CO and RENO, NV, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, has entered into a strategic collaboration with Renown...